Gambro Renal Products (GRP) announced today that it has received U.S. FDA 510(k) clearance for the Molecular Adsorbents Recirculating System® in cases of drug overdose and poisoning. The MARS® Therapy will be available in the U.S. toward the end of 2005 for drug overdose and poisoning treatment.

Good post!!!!!!! Thank you.........
Posted by: Regulatory Affairs Consultant | May 25, 2009 at 09:34